CITF Will Take Serious Action Against Those Responsible Over AZ Vaccine Registration Chaos

Thirsty for JUICE content? Quench your cravings on our Instagram, TikTok and WhatsApp
(source: The Star)

In a statement yesterday (26 May), the Covid-19 Immunisation Task Force (CITF) said that action will be taken against quarters responsible for causing technical problems during the registration for the second round of the opt-in AstraZeneca Covid-19 vaccine programme.

It noted that there was a technical problem resulting in difficulties among applicants accessing some buttons on the registration site at

“The CITF views this technical problem seriously and action will be taken against quarters (who caused the problem) in the interest of the public and the country,” it said.

It was earlier reported that all slots for the second round of the voluntary AstraZeneca vaccine were taken up in less than 90 minutes after registration was opened for those aged 18 and above on 25 May.

(source: SoyaCincau)

Beginning with a slight delay in the registration which started at 12.15 pm instead of noon as announced, the process was met with frustration and anger among netizens who could not access some features available on the registration site.

The CITF said a total of 956,609 slots were taken up during the registration process.

The task force also noted that 275,208 slots were taken up among senior citizens when the second round of the opt-in programme was first opened to senior citizens aged 60 and above on May 23.

In addition, the CITF has also included 29,183 people in the waiting list from the first round of the opt-in programme for the AstraZeneca vaccine in the second round of the programme.

“We are aware that there are many who are interested to get vaccinated but have failed to secure a slot (under the second round of the opt-in AstraZeneca vaccine programme).

“We would like to reiterate that those who have registered under the National Covid-19 Immunisation Programme will get vaccinated under the programme especially when the supply of the vaccines increases in the coming months.

“Again, we would like to apologise for the inconvenience and that we are open to feedback and criticism from all quarters,” read the statement.